![Jeffrey Silber](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 579 662 $ au 31/07/2026
Jeffrey Silber currently works at Ironwood Pharmaceuticals, Inc., as Head-Research & Drug Development from 2026.
Dr. Silber also formerly worked at Vedanta Biosciences, Inc., as Chief Medical Officer from 2020 to 2026.
Dr. Silber received his undergraduate degree from Harvard University and doctorate degree from Albert Einstein College of Medicine, Inc.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/07/2026 | 137 036 ( 0,08 % ) | 579 662 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Directeur Technique/Scientifique/R&D | 20/07/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
Vedanta Biosciences, Inc.
 Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Directeur Technique/Scientifique/R&D | 01/07/2026 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albert Einstein College of Medicine, Inc.
 Albert Einstein College of Medicine, Inc. Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
